François-Clément Bidard, MD, PhD, is a leading medical oncologist in France, specializing in breast cancer treatment and research. As a Professor of Medicine at Institut Curie & Université Paris-Saclay, he is renowned as one of the best breast cancer specialists in France, with expertise in metastatic breast cancer, tumor biomarkers, and circulating tumor DNA (ctDNA). Dr. Bidard is the co-coordinator of breast cancer research at Institut Curie, the #1 breast cancer center in France, and serves as the Vice-Chair of Unicancer's Breast Cancer Research Group (UCBG). With a distinguished career in oncology, he has contributed extensively to cutting-edge cancer research and personalized treatments, particularly in liquid biopsy techniques and early cancer detection. His pioneering work in ctDNA and circulating tumor cells (CTCs) has positioned him among the top oncologists in Paris and a famous cancer researcher in Europe, making him a trusted name in breast cancer treatment.
Dr. François-Clément Bidard is a world-renowned breast cancer expert, recognized as a leading oncologist for metastatic breast cancer and an expert in tumor biomarkers and ctDNA. His groundbreaking research on circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) has significantly advanced personalized cancer treatment, enhancing early detection, prognosis assessment, and precision medicine approaches. With an extensive background in clinical oncology and translational research, he is regarded as one of the best breast cancer doctors in France. His work continues to influence breast cancer management worldwide, solidifying his reputation as a top cancer specialist in Paris and a famous researcher in breast cancer treatment.